未登录 分享 收藏
EFFECTIVENESS, SAFETY AND COST PER SVR IN GT4 HEPATITIS C PATIENTS TREATED WITH SOFOSBUVIR-BASED THERAPIES IN REAL CLINICAL PRACTICE: A FRANCO-GERMAN EXPERIENCE (SOFEX-4) Pais, R.; Buggisch, P.; Moussalli, J.; Benhamou, Y.; Wedemeyer, H.; Asselah, T.; Bec, M.; Schwarzbard, J.; Ratziu, V.; Petersen, J. 分享 收藏
HBsAg CLEARANCE AFTER ADDITION OF 48 WEEKS OF PEGIFN IN HBeAg NEGATIVE CHB PATIENTS ON NUCLEOS(T)IDE THERAPY WITH UNDETECTABLE HBVDNA FOR AT LEAST ONE YEAR: FINAL RESULTS FROM ANRS-HB06 PEGAN STUDY: MULTICENTER RANDOMIZED CONTROLLED PHASE III TRIAL Bourliere, M.; Rabiega, P.; Ganne-Carrie, N.; Serfaty, L.; Marcellin, P.; Pouget, N.; Guyader, D.; Hezode, C.; Picon, M.; Causse, X.; Leroy, V.; Bronowicki, J. P.; Riachi, G.; Rosa, I.; Attali, P.; Molina, J. M.; Bacq, Y.; Tran, A.; Grange, J. D.; Zoulim, F.; Fontaine, H.; Bertucci, I.; Bouvier-Alias, M.; Carrat, F.; Benhamou, Y. 分享 收藏
EFFICACY OF THE ORAL SOFOSBUVIR-BASED COMBINATIONS IN HCV GENOTYPE 4-MONO-INFECTED PATIENTS FROM THE FRENCH OBSERVATIONAL COHORT ANRS CO22 HEPATHER Fontaine, H.; Hezode, C.; Zoulim, F.; Samuel, D.; Bourliere, M.; Haour, G.; Dorival-Mouly, C.; Leroy, V.; De Ledinghen, V.; Lucier, S.; Larrey, D.; Tran, A.; Metivier, S.; Benhamou, Y.; Hubert-Fouchard, I.; Habersetzer, F.; Marcellin, P.; Mathurin, P.; Alric, L.; Bronowicki, J. -P.; Guyader, D.; Loustaud-Ratti, V.; Minello, A.; Riachi, G.; Rosa, I.; Simony, M.; Diallo, A.; Carrat, F.; Pol, S. 分享 收藏
SAFETY AND EFFICACY OF THE COMBINATION DACLATASVIR-SOFOSBUVIR IN HCV GENOTYPE 1-MONO-INFECTED PATIENTS FROM THE FRENCH OBSERVATIONAL COHORT ANRS CO22 HEPATHER Pol, S.; Bourliere, M.; Lucier, S.; De Ledinghen, V.; Zoulim, F.; Dorival-Mouly, C.; Metivier, S.; Larrey, D.; Tran, A.; Hezode, C.; Bronowicki, J. -P.; Samuel, D.; Marcellin, P.; Zarski, J. -P.; Minello, A.; Alric, L.; Trinchet, J. -C.; Nahon, P.; Guyader, D.; Chazouilleres, O.; Riachi, G.; Loustaud-Ratti, V.; Causse, X.; Mathurin, P.; Hubert-Fouchard, I.; Rosa, I.; Benhamou, Y.; Gournay, J.; Raabe, J. -J.; Raffi, F.; Petrov-Sanchez, V.; Diallo, A.; Fontaine, H.; Carrat, F. 分享 收藏
Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial Benhamou, Yves; Moussalli, Joseph; Ratziu, Vlad; Lebray, Pascal; De Backer, Katrien; De Meyer, Sandra; Ghys, Anne; Luo, Donghan; Picchio, Gaston R.; Beumont, Maria 分享 收藏
LONG TERM SURVIVAL OF LIVER FIBROSIS AFTER VIROLOGICAL CURE (SVR) IN HIV-HCV COINFECTED PATIENTS: A WORRISOME LATENT DISEASE? Poynard, T.; Valantin, M. A.; Munteanu, M.; Moussalli, J.; Thabut, D.; Lebray, P.; Rudler, M.; Ngo, Y.; Thibault, V.; Charlotte, F.; Imbert-Bismut, F.; Benhamou, Y.; Ratziu, V.; Katlama, C. 分享 收藏
HARPE STUDY: PREVALENCE OF RENAL ABNORMALITIES IN CHRONIC HBV INFECTION Amet, S.; Bronowicki, J-P; Thabut, D.; Zoulim, F.; Bourliere, M.; Mathurin, P.; De Ledinghen, V.; Benhamou, Y.; Larrey, D.; Bruce, E.; Janus, N.; Launay-Vacher, V.; Deray, G.; Pol, S. 分享 收藏
100% SVR IN IL28B CC PATIENTS TREATED WITH 12 WEEKS OF TELAPREVIR, PEGINTERFERON AND RIBAVIRIN IN THE PROVE2 TRIAL Bronowicki, J-P; Hezode, C.; Bengtsson, L.; Pol, S.; Bourliere, M.; Serfaty, L.; de Ledinghen, V.; Tran, A.; Benhamou, Y.; Grange, J-D; Mathurin, P.; Marcellin, P.; Trepo, C.; Zarski, J-P; Seepersaud, S.; Kelliher, K.; Botfield, M.; Pawlotsky, J-M 分享 收藏
HCV-GENOFIBROTEST: A COMBINATION OF VIRAL, LIVER AND GENOMIC (IL28B, ITPA, UGT1A1) BIOMARKERS FOR PREDICTING TREATMENT RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C Costa, J. M.; Telehin, D.; Munteanu, M.; Kobryn, T.; Ngo, Y.; Thibault, V.; Moussalli, J.; Ratziu, V.; Benhamou, Y.; Koz'ko, V.; Dubins'ka, G.; Poveda, J. D.; Poynard, T. 分享 收藏
Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study Dominguez, Stephanie; Ghosn, Jade; Peytavin, Gilles; Guiguet, Marguerite; Tubiana, Roland; Valantin, Marc Antoine; Murphy, Robert; Bricaire, Francois; Benhamou, Yves; Katlama, Christine 分享 收藏
DYNAMICS OF APOPTOTIC ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH ALBINTERFERON ALFA-2B OR PEGINTERFERON ALFA-2A Kronenberger, B.; Herrmann, E.; Chen, C.; Fiscella, M.; Subramanian, G.; McHutchison, J.; Benhamou, Y.; Sulkowski, M.; Nelson, D.; Zeuzem, S. 分享 收藏
EVALUATING VIROLOGIC RESPONSE WITHIN 2-4 WEEKS HAS HIGH POSITIVE/NEGATIVE PREDICTIVE VALUES FOR SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C DURING TREATMENT Neumann, A.; Shiffman, M.; Ferenci, P.; Foster, G.; Yoshida, E.; Pianko, S.; Sulkowski, M.; Zeuzem, S.; Benhamou, Y.; Nelson, D.; McHutchison, J.; Pulkstenis, E.; Subramanian, G. 分享 收藏
HCV PROTEASE INHIBITOR RESTORES INSULIN SENSITIVITY IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS Moucari, R.; Forestier, N.; Larrey, D.; Guyader, D.; Couzigou, P.; Benhamou, Y.; Voitot, H.; Vidaud, M.; Seiwert, S.; Bradford, B.; Zeuzem, S.; Marcellin, P. 分享 收藏
分享 收藏
LONGITUDINAL PROSPECTIVE COMPARISON OF FIBROSURE AND TRANSIENT ELASTOGRAPHY IN RELATION TO VIROLOGIC RESPONSE: A SUBSTUDY OF THE PHASE 3 ALBINTERFERON ALFA-2B TRIALS Patel, K.; Friedrich-Rust, M.; Torbenson, M.; Zhu, Y.; Pulkstenis, E.; Subramanian, G.; McHutchison, J.; Nelson, D.; Sulkowski, M.; Benhamou, Y.; Zeuzem, S. 分享 收藏
分享 收藏
BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN Kukolj, G.; Benhamou, Y.; Manns, M. P.; Bourliere, M.; Pol, S.; Schuchmann, M.; Cartier, M.; Huang, D.; Lagace, L.; Steinmann, G.; Stern, J. O. 分享 收藏
SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C Larrey, D.; Benhamou, Y.; Lohse, A. W.; Trepo, C.; Moelleken, C.; Bronowicki, J-P.; Arasteh, K.; Bourliere, M.; Heim, M.; Enriquez, J.; Erhardt, A.; Zarski, J. -P; Wiest, R.; Gerlach, T.; Wedemeyer, H.; Berg, T.; Stern, J.; Wu, K.; Abdallah, N.; Nehmiz, G.; Boecher, W.; Steffgen, J. 分享 收藏
EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C Nelson, D.; Benhamou, Y.; Chuang, W. L.; Lawitz, E.; Flisiak, R.; Rodriguez-Torres, M.; Bain, V.; Patel, K.; Cronin, P. W.; Pulkstenis, E.; Subramanian, G. M.; McHutchison, J. G. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
